The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1

This first volume chronicles the early stages of the SARS-Cov-2 (COVID-19) outbreak and worldwide spread, outlining the roles of various disciplines in therapeutic and control measures. It documents the epidemiologic response from China, clinical evaluation, pathology, and initial therapeutics from the first 6 months and onwards.

Format: Hardback
Length: 550 pages
Publication date: 27 April 2022
Publisher: Royal Society of Chemistry

This first volume chronicles the early stages of the outbreak and worldwide spread of SARS-Cov-2 (COVID-19) and delineates the role of several disciplines in therapeutic and control measures. Documenting the epidemiologic response from China, the clinical evaluation, pathology, and initial therapeutics that were available during the first 6 months and onwards of the outbreak, this book records how the response to the pandemic was mounted and how various branches of science and research combined to rapidly expand our understanding of the disease.

The first volume of this comprehensive work chronicles the early stages of the outbreak and global spread of SARS-Cov-2 (COVID-19), highlighting the critical role played by various disciplines in therapeutic and control measures. It provides a detailed account of the epidemiologic response from China, encompassing the clinical evaluation, pathology, and initial therapeutics employed during the initial months of the pandemic. The book meticulously records the mounting efforts to combat the disease and how different branches of science and research seamlessly converged to expedite our understanding of COVID-19.

The early chapters of the volume delve into the epidemiological landscape, shedding light on the initial outbreak in Wuhan, China, and its rapid spread to other parts of the world. The authors provide a comprehensive overview of the clinical manifestations, laboratory testing, and treatment strategies employed at that time. They also discuss the challenges faced by healthcare systems and the scientific community in responding to the crisis.

As the pandemic unfolded, the clinical evaluation of COVID-19 became a pivotal aspect of understanding the disease and developing effective therapies. The authors describe the clinical characteristics of the disease, including the range of symptoms, severity, and potential complications. They also explore the role of imaging techniques, such as CT scans and chest X-rays, in diagnosing and monitoring patients.

Pathology plays a crucial role in understanding the mechanisms of COVID-19 and developing targeted treatments. The authors provide a detailed account of the pathological findings observed in patients, including the impact of the virus on the respiratory and cardiovascular systems. They also discuss the role of genetic testing in identifying potential treatments and the development of vaccines.

Initial therapeutics for COVID-19 were primarily based on repurposed drugs and experimental treatments. The authors discuss the challenges and successes in developing and testing these treatments, including the use of antiviral drugs, corticosteroids, and immunomodulators. They also highlight the importance of clinical trials and the rapid dissemination of information to inform treatment decisions.

Throughout the first volume, the authors emphasize the multidisciplinary approach required to combat COVID-19. They highlight the collaboration between healthcare professionals, scientists, researchers, and policymakers in developing and implementing effective strategies. They also discuss the role of public health measures, such as social distancing, mask-wearing, and lockdowns, in controlling the spread of the disease.

The second volume of this work will continue to explore the ongoing pandemic, focusing on the clinical evaluation, pathology, and therapeutic developments that have emerged since the initial stages of the outbreak. It will also examine the long-term impacts of COVID-19 on public health, the healthcare system, and society as a whole.

In conclusion, this first volume of the COVID-19 Handbook provides a comprehensive and timely account of the early stages of the outbreak and global spread of SARS-Cov-2 (COVID-19). It serves as a valuable resource for healthcare professionals, scientists, researchers, and policymakers seeking to understand the disease and develop effective strategies for therapeutic and control measures. The multidisciplinary approach and collaborative efforts highlighted in the book are crucial in navigating the ongoing pandemic and ensuring a better future for all.

Weight: 1055g
Dimension: 234 x 156 (mm)
ISBN-13: 9781839163067